These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25584393)

  • 1. Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activity.
    Perez HL; Chaudhry C; Emanuel SL; Fanslau C; Fargnoli J; Gan J; Kim KS; Lei M; Naglich JG; Traeger SC; Vuppugalla R; Wei DD; Vite GD; Talbott RL; Borzilleri RM
    J Med Chem; 2015 Feb; 58(3):1556-62. PubMed ID: 25584393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582).
    Hennessy EJ; Adam A; Aquila BM; Castriotta LM; Cook D; Hattersley M; Hird AW; Huntington C; Kamhi VM; Laing NM; Li D; MacIntyre T; Omer CA; Oza V; Patterson T; Repik G; Rooney MT; Saeh JC; Sha L; Vasbinder MM; Wang H; Whitston D
    J Med Chem; 2013 Dec; 56(24):9897-919. PubMed ID: 24320998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of tetrahydroisoquinoline-based bivalent heterodimeric IAP antagonists.
    Kim KS; Zhang L; Williams D; Perez HL; Stang E; Borzilleri RM; Posy S; Lei M; Chaudhry C; Emanuel S; Talbott R
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5022-9. PubMed ID: 25278234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of D-ring fused 1,2,3-thiadiazole dehydroepiandrosterone derivatives as antitumor agents.
    Cui HW; Peng S; Gu XZ; Chen H; He Y; Gao W; Lv F; Wang JH; Wang Y; Xie J; Liu MY; Yi Z; Qiu WW
    Eur J Med Chem; 2016 Mar; 111():126-37. PubMed ID: 26866967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP.
    Chessari G; Buck IM; Day JE; Day PJ; Iqbal A; Johnson CN; Lewis EJ; Martins V; Miller D; Reader M; Rees DC; Rich SJ; Tamanini E; Vitorino M; Ward GA; Williams PA; Williams G; Wilsher NE; Woolford AJ
    J Med Chem; 2015 Aug; 58(16):6574-88. PubMed ID: 26218264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAR and in vivo evaluation of 4-aryl-2-aminoalkylpyrimidines as potent and selective Janus kinase 2 (JAK2) inhibitors.
    Forsyth T; Kearney PC; Kim BG; Johnson HW; Aay N; Arcalas A; Brown DS; Chan V; Chen J; Du H; Epshteyn S; Galan AA; Huynh TP; Ibrahim MA; Kane B; Koltun ES; Mann G; Meyr LE; Lee MS; Lewis GL; Noguchi RT; Pack M; Ridgway BH; Shi X; Takeuchi CS; Zu P; Leahy JW; Nuss JM; Aoyama R; Engst S; Gendreau SB; Kassees R; Li J; Lin SH; Martini JF; Stout T; Tong P; Woolfrey J; Zhang W; Yu P
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7653-8. PubMed ID: 23127890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells.
    Shiokawa Z; Hashimoto K; Saito B; Oguro Y; Sumi H; Yabuki M; Yoshimatsu M; Kosugi Y; Debori Y; Morishita N; Dougan DR; Snell GP; Yoshida S; Ishikawa T
    Bioorg Med Chem; 2013 Dec; 21(24):7938-54. PubMed ID: 24169315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.
    Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S
    J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines.
    Shi B; Cao R; Fan W; Guo L; Ma Q; Chen X; Zhang G; Qiu L; Song H
    Eur J Med Chem; 2013 Feb; 60():10-22. PubMed ID: 23279863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.
    Bae I; Kim D; Choi J; Kim J; Kim M; Park B; Kim YH; Ahn YG; Hyung Kim H; Kim DK
    Bioorg Med Chem Lett; 2021 Feb; 34():127676. PubMed ID: 33166687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors.
    Brasca MG; Nesi M; Avanzi N; Ballinari D; Bandiera T; Bertrand J; Bindi S; Canevari G; Carenzi D; Casero D; Ceriani L; Ciomei M; Cirla A; Colombo M; Cribioli S; Cristiani C; Della Vedova F; Fachin G; Fasolini M; Felder ER; Galvani A; Isacchi A; Mirizzi D; Motto I; Panzeri A; Pesenti E; Vianello P; Gnocchi P; Donati D
    Bioorg Med Chem; 2014 Sep; 22(17):4998-5012. PubMed ID: 25009002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins.
    Sun H; Lu J; Liu L; Yi H; Qiu S; Yang CY; Deschamps JR; Wang S
    J Med Chem; 2010 Sep; 53(17):6361-7. PubMed ID: 20684551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship studies of cytotoxic vinorelbine amide analogues.
    Hu L; Song W; Meng Y; Guo D; Liu X; Hu L
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7547-50. PubMed ID: 23107481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palladacycle (BPC) antitumour activity against resistant and metastatic cell lines: the relationship with cytosolic calcium mobilisation and cathepsin B activity.
    Bechara A; Barbosa CM; Paredes-Gamero EJ; Garcia DM; Silva LS; Matsuo AL; Nascimento FD; Rodrigues EG; Caires AC; Smaili SS; Bincoletto C
    Eur J Med Chem; 2014 May; 79():24-33. PubMed ID: 24709226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer.
    Zhang L; Fan C; Guo Z; Li Y; Zhao S; Yang S; Yang Y; Zhu J; Lin D
    Eur J Med Chem; 2013 Nov; 69():833-41. PubMed ID: 24121234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiophene-3-carboxamide analogue of annonaceous acetogenins as antitumor drug lead.
    Kojima N; Fushimi T; Tatsukawa T; Tanaka T; Okamura M; Akatsuka A; Yamori T; Dan S; Iwasaki H; Yamashita M
    Eur J Med Chem; 2014 Oct; 86():684-9. PubMed ID: 25226228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents.
    Li D; Xu S; Cai H; Pei L; Wang L; Wu X; Yao H; Jiang J; Sun Y; Xu J
    ChemMedChem; 2013 May; 8(5):812-8. PubMed ID: 23520191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure--activity relationships of N²-alkylated quaternary β-carbolines as novel antitumor agents.
    Zhang G; Cao R; Guo L; Ma Q; Fan W; Chen X; Li J; Shao G; Qiu L; Ren Z
    Eur J Med Chem; 2013 Jul; 65():21-31. PubMed ID: 23688697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo.
    Wang XM; Xu J; Li YP; Li H; Jiang CS; Yang GD; Lu SM; Zhang SQ
    Eur J Med Chem; 2013 Sep; 67():243-51. PubMed ID: 23871904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents.
    Cao R; Fan W; Guo L; Ma Q; Zhang G; Li J; Chen X; Ren Z; Qiu L
    Eur J Med Chem; 2013 Feb; 60():135-43. PubMed ID: 23291116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.